← All Sponsors
SPONSOR

Cascade Pharmaceuticals, Inc

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Primary Biliary Cholangitis
NCT07282353 Phase 3
Recruiting

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

Primary Biliary Cholangitis
China View Trial →